Myasthenia gravis: Managing newly diagnosed and poorly controlled MG

These patient cases have been developed with the assistance of Dr. Nicholas Silvestri (Department of Neurology, University at Buffalo – Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA) and Prof. Neelam Goyal (Clinical Associate Professor of Neurology and Neurological Sciences at Stanford University, Palo Alto, CA, USA). This program was supported by argenx, US.

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. In the United States, full prescribing information is available from the US Food and Drug Administration (fda.gov).

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for healthcare professionals practicing in the USA. To proceed, please confirm that you are a healthcare professional practicing in the USA.

Modules

• A 63-year-old woman with known generalized myasthenia gravis and poorly controlled symptoms

• A 75-year-old man with new-onset neuromuscular weakness